chartexchange

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

GlobeNewswire Inc. | Nov 11, 2026 4:05 PM EST

IRVINE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today reported recent business highlights and financial results for the third quarter ended September 30, 2026.

Read original article